Alphamab Oncology (HKG:9966) dosed the first patient in the phase 2 clinical study of JSKN033, according to a Wednesday filing with the Hong Kong bourse.
The firm plans to study the medicine as a first-line treatment of advanced cervical cancer.
Related Articles
Asia
Anhui Honglu Steel Construction Elects Chair
Anhui Honglu Steel Construction (SHE:002541) elected Wan Shengping as chair, according to a Wednesday filing with the Shenzhen bourse.The election followed a meeting of the company's directors to formalize the leadership transition. Wan Shengping assumed the role immediately following the board's approval.The appointment came as the steel structure specialist continued to navigate shifting demand in the industrial construction sector.Shares of the construction company were down 5% in recent trade.
$SHE:002541
Asia
Market Chatter: China Watchdog Conditionally Approves Tencent Music's Acquisition of Ximalaya
China's competition watchdog conditionally approved Tencent Music Entertainment's (HKG:1698) bid to acquire Chinese audio platform Ximalaya, an online audio platform, according to media reports Tuesday.According to the State Administration for Market Regulation's notice, Tencent and Ximalaya are required to meet certain commitments, including not raising prices for online audio streaming platforms.Tencent Music agreed last year to acquire Ximalaya for $1.26 billion in cash and an issuance of stock.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$HKG:1698
Asia
S&P Raises Bohai Leasing Unit's Rating to BBB
S&P Global raised the credit rating of Bohai Leasing (SHE:000415) unit Avolon Holdings to BBB from BBB-, with a stable outlook.The rating agency cited Avolon Holdings' strong order deliveries, fleet management and financial performance for the upgrade, according to a Wednesday filing with the Shenzhen bourse.Shares of the leasing company were down 4% in recent trade.
$SHE:000415